Cytokine signaling in the brain: Putting a SOCS in it?

被引:53
作者
Wang, JP [1 ]
Campbell, IL [1 ]
机构
[1] Scripps Res Inst, La Jolla, CA USA
关键词
CNS; cytokine; JAK/STAT; signal transduction; SOCS;
D O I
10.1002/jnr.10145
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A new family of cytokine-inducible proteins, termed "suppressors of cytokine signaling" (SOCS), was discovered recently; these proteins function as negative regulators of signaling pathways involved in the cellular actions of many cytokines, growth factors, and hormones. Gene manipulation studies in mice point to the central importance of individual SOCS proteins in maintaining homeostasis by limiting cellular responses to specific cytokines or growth factors in a variety of different physiological systems. Cytokines modulate a wide variety of biological responses in the CNS, so members of the SOCS family might play crucial roles in regulating intracellular signaling by these effectors in both normal and disease states. Although to date studies of the neurobiology of the SOCS family have been limited, we know that many SOCS genes are constitutively expressed in the developing and adult brain, whereas the expression of others, particularly the SOCS1 and SOCS3 genes, can be highly regulated. Furthermore, roles for the SOCS are now evident in the modulation of neuroimmunoendocrine functions affected by a variety of cytokines, including leptin and members of the growth hormone and the interleukin-6/gp130 superfamilies. Overall, these findings point to the SOCS as likely crucial negative modulators in the temporal and spatial regulation and intensity of cytokine signaling and therefore actions in the CNS. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:423 / 427
页数:5
相关论文
共 41 条
[1]   Functional roles of STAT family proteins: Lessons from knockout mice [J].
Akira, S .
STEM CELLS, 1999, 17 (03) :138-146
[2]   SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine [J].
Alexander, WS ;
Starr, R ;
Fenner, JE ;
Scott, GL ;
Handman, E ;
Sprigg, NS ;
Corbin, JE ;
Cornish, AL ;
Darwiche, R ;
Owczarek, CM ;
Kay, TWH ;
Nicola, NA ;
Hertzog, PJ ;
Metcalf, D ;
Hilton, DJ .
CELL, 1999, 98 (05) :597-608
[3]   Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion [J].
Auernhammer, CJ ;
Chesnokova, V ;
Bousquet, C ;
Melmed, S .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (07) :954-961
[4]   Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: Evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis [J].
Auernhammer, CJ ;
Melmed, S .
ENDOCRINOLOGY, 1999, 140 (04) :1559-1566
[5]   Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4(+) T cells via CD40 ligand [J].
Balashov, KE ;
Smith, DR ;
Khoury, SJ ;
Hafler, DA ;
Weiner, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (02) :599-603
[6]   Identification of SOCS-3 as a potential mediator of central leptin resistance [J].
Bjorbaek, C ;
Elmquist, JK ;
Frantz, JD ;
Shoelson, SE ;
Flier, JS .
MOLECULAR CELL, 1998, 1 (04) :619-625
[7]   Activation of SOCS-3 messenger ribonucleic acid in the hypothalamus by ciliary neurotrophic factor [J].
Bjorbæk, C ;
Elmquist, JK ;
El-Haschimi, K ;
Kelly, J ;
Ahima, RS ;
Hileman, S ;
Flier, JS .
ENDOCRINOLOGY, 1999, 140 (05) :2035-2043
[8]   The role of SOCS-3 in leptin signaling and leptin resistance [J].
Bjorbæk, C ;
El-Haschimi, K ;
Frantz, JD ;
Flier, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :30059-30065
[9]   Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor [J].
Bousquet, C ;
Susini, C ;
Melmed, S .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (09) :1277-1285
[10]   Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: Evidence for an IL-10-induced pathway that is independent of STAT protein activation [J].
Cassatella, MA ;
Gasperini, S ;
Bovolenta, C ;
Calzetti, F ;
Vollebregt, M ;
Scapini, P ;
Marchi, M ;
Suzuki, R ;
Suzuki, A ;
Yoshimura, A .
BLOOD, 1999, 94 (08) :2880-2889